Table of Content

Table of Contents

Global Diabetic Neuropathic Pain Drug Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 AZD-5213 -Product Introduction and Major Manufacturers
1.1.2 Clonidine Hydrochloride -Product Introduction and Major Manufacturers
1.1.3 Duloxetine Hydrochloride DR -Product Introduction and Major Manufacturers
1.1.4 E-52862 -Product Introduction and Major Manufacturers
1.1.5 Filgrastim -Product Introduction and Major Manufacturers
1.1.6 GERPOOI -Product Introduction and Major Manufacturers
1.1.7 GRC-17536 -Product Introduction and Major Manufacturers
1.1.8 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Diabetic Neuropathic Pain Drug Status and Prospect (2015-2026)
2.1.1 China Diabetic Neuropathic Pain Drug Market Size and Growth Rate (2015-2026)
2.1.2 China Diabetic Neuropathic Pain Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Diabetic Neuropathic Pain Drug Status and Prospect (2015-2026)
2.2.1 EU Diabetic Neuropathic Pain Drug Market Size and Growth Rate (2015-2026)
2.2.2 EU Diabetic Neuropathic Pain Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Diabetic Neuropathic Pain Drug Status and Prospect (2015-2026)
2.3.1 USA Diabetic Neuropathic Pain Drug Market Size and Growth Rate (2015-2026)
2.3.2 USA Diabetic Neuropathic Pain Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Diabetic Neuropathic Pain Drug Status and Prospect (2015-2026)
2.4.1 Japan Diabetic Neuropathic Pain Drug Market Size and Growth Rate (2015-2026)
2.4.2 Japan Diabetic Neuropathic Pain Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Diabetic Neuropathic Pain Drug Status and Prospect (2015-2026)
2.5.1 India Diabetic Neuropathic Pain Drug Market Size and Growth Rate (2015-2026)
2.5.2 India Diabetic Neuropathic Pain Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Diabetic Neuropathic Pain Drug Status and Prospect (2015-2026)
2.6.1 Southeast Asia Diabetic Neuropathic Pain Drug Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Diabetic Neuropathic Pain Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Diabetic Neuropathic Pain Drug Status and Prospect (2015-2026)
2.7.1 South America Diabetic Neuropathic Pain Drug Market Size and Growth Rate (2015-2026)
2.7.2 South America Diabetic Neuropathic Pain Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Diabetic Neuropathic Pain Drug Status and Prospect (2015-2026)
2.8.1 Diabetic Neuropathic Pain Drug Market Size and Growth Rate (2015-2026)
2.8.2 Diabetic Neuropathic Pain Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Diabetic Neuropathic Pain Drug Market Assessment by Segment
3.1 Global Diabetic Neuropathic Pain Drug Capacity and Growth Rate
3.2 Global Diabetic Neuropathic Pain Drug Sales by Type
3.3 Global Diabetic Neuropathic Pain Drug Sales Revenue by Type
3.4 Global Diabetic Neuropathic Pain Drug Consumption by Application
4 Global Diabetic Neuropathic Pain Drug Market Assessment by Regions
4.1 Global Diabetic Neuropathic Pain Drug Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Diabetic Neuropathic Pain Drug Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Diabetic Neuropathic Pain Drug Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Diabetic Neuropathic Pain Drug Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Diabetic Neuropathic Pain Drug Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Diabetic Neuropathic Pain Drug Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Diabetic Neuropathic Pain Drug Sales Market Share of Manufacturers (2019-2020)
6.3 Global Diabetic Neuropathic Pain Drug Sales Revenue Market Share of Manufacturers (2019-2020)

7 Diabetic Neuropathic Pain Drug Competitive Analysis
7.1 Astellas Pharma Inc.
7.1.1 Astellas Pharma Inc. Company Profiles
7.1.2 Astellas Pharma Inc. Product Introduction
7.1.3 Astellas Pharma Inc. Diabetic Neuropathic Pain Drug Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 AstraZeneca Plc
7.2.1 AstraZeneca Plc Company Profiles
7.2.2 AstraZeneca Plc Product Introduction
7.2.3 AstraZeneca Plc Diabetic Neuropathic Pain Drug Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 BioDelivery Sciences International, Inc.
7.3.1 BioDelivery Sciences International, Inc. Company Profiles
7.3.2 BioDelivery Sciences International, Inc. Product Introduction
7.3.3 BioDelivery Sciences International, Inc. Diabetic Neuropathic Pain Drug Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Boehringer Ingelheim GmbH
7.4.1 Boehringer Ingelheim GmbH Company Profiles
7.4.2 Boehringer Ingelheim GmbH Product Introduction
7.4.3 Boehringer Ingelheim GmbH Diabetic Neuropathic Pain Drug Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Daiichi Sankyo Company, Limited
7.5.1 Daiichi Sankyo Company, Limited Company Profiles
7.5.2 Daiichi Sankyo Company, Limited Product Introduction
7.5.3 Daiichi Sankyo Company, Limited Diabetic Neuropathic Pain Drug Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Dong-A Socio Group
7.6.1 Dong-A Socio Group Company Profiles
7.6.2 Dong-A Socio Group Product Introduction
7.6.3 Dong-A Socio Group Diabetic Neuropathic Pain Drug Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Eli Lilly and Company
7.7.1 Eli Lilly and Company Company Profiles
7.7.2 Eli Lilly and Company Product Introduction
7.7.3 Eli Lilly and Company Diabetic Neuropathic Pain Drug Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Glenmark Pharmaceuticals Ltd.
7.8.1 Glenmark Pharmaceuticals Ltd. Company Profiles
7.8.2 Glenmark Pharmaceuticals Ltd. Product Introduction
7.8.3 Glenmark Pharmaceuticals Ltd. Diabetic Neuropathic Pain Drug Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Hydra Biosciences, Inc.
7.9.1 Hydra Biosciences, Inc. Company Profiles
7.9.2 Hydra Biosciences, Inc. Product Introduction
7.9.3 Hydra Biosciences, Inc. Diabetic Neuropathic Pain Drug Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Immune Pharmaceuticals Inc.
7.10.1 Immune Pharmaceuticals Inc. Company Profiles
7.10.2 Immune Pharmaceuticals Inc. Product Introduction
7.10.3 Immune Pharmaceuticals Inc. Diabetic Neuropathic Pain Drug Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 Laboratorios Del Dr. Esteve S.A.
7.12 Lohocla Research Corporation
7.13 Mertiva AB
7.14 Novaremed
7.15 Pharmaleads
7.16 RAPID Pharmaceuticals AG
7.17 Relmada Therapeutics, Inc.
7.18 Sphaera Pharma Pvt. Ltd.
7.19 Theravasc, Inc.
8 Conclusion

List of Figure

List of Tables and Figures

Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
Figure Global Diabetic Neuropathic Pain Drug Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2015-2026)
Table CAGR in Terms of Production of Each Application (2015-2026)
Table Global Diabetic Neuropathic Pain Drug Sales (K Unit) by Type (2015-2026)
Figure Global Diabetic Neuropathic Pain Drug Sales (K Unit) and Growth Rate (2015-2026)
Figure Global Diabetic Neuropathic Pain Drug Sales Market Share (%) by Type (2019 -2020)
Table Global Diabetic Neuropathic Pain Drug Sales Value (Million USD) by Type (2015-2026)
Figure Global Diabetic Neuropathic Pain Drug Sales Value (Million USD) and Growth Rate (2015-2026)
Figure Global Diabetic Neuropathic Pain Drug Sales Value Market Share (%) by Type (2019-2020)
Table Global Diabetic Neuropathic Pain Drug Sales (K Unit) by Application (2015-2026)
Figure China Diabetic Neuropathic Pain Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table China Diabetic Neuropathic Pain Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure EU Diabetic Neuropathic Pain Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table EU Diabetic Neuropathic Pain Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure North America Diabetic Neuropathic Pain Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table North America Diabetic Neuropathic Pain Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Japan Diabetic Neuropathic Pain Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Japan Diabetic Neuropathic Pain Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure India Diabetic Neuropathic Pain Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table India Diabetic Neuropathic Pain Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Southeast Asia Diabetic Neuropathic Pain Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Southeast Asia Diabetic Neuropathic Pain Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure South America Diabetic Neuropathic Pain Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table South America Diabetic Neuropathic Pain Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Middle East and Africa Diabetic Neuropathic Pain Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Middle East and Africa Diabetic Neuropathic Pain Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Table Global Diabetic Neuropathic Pain Drug Capacity (K Units) and Growth Rate (2015-2026)
Figure Global Diabetic Neuropathic Pain Drug Capacity (K Units) and Growth Rate (2015-2026)
Table Global Diabetic Neuropathic Pain Drug Sales (Unit) by Type (2015-2026)
Figure Global Diabetic Neuropathic Pain Drug Sales(Unit) and Growth Rate (2015-2026)
Table Sales Market Share (%) by Type (2019-2026)
Table Global Diabetic Neuropathic Pain Drug Sales Revenue (Million USD) by Type (2015-2026)
Figure Global Diabetic Neuropathic Pain Drug Sales Revenue (Million USD) and Growth Rate (2015-2026)
Table Sales Revenue Market Share (%) by Type (2019-2026)
Table Global Diabetic Neuropathic Pain Drug Consumption (Unit) by Application (2015-2026)
Figure Global Diabetic Neuropathic Pain Drug Consumption (Unit) and Growth Rate (2015-2026)
Table Consumption Market Share (%) by Application (2019-2026)
Table Global Diabetic Neuropathic Pain Drug Production (K Unite) by Regions (2015-2020)
Table Global Diabetic Neuropathic Pain Drug CAGR (%) in term of Production and Market Share by Regions (2015-2026)
Figure Global Diabetic Neuropathic Pain Drug Production Share by Regions (2019-2020)
Table Global Diabetic Neuropathic Pain Drug Sales (K Unite) by Regions (2015-2020)
Table Global Diabetic Neuropathic Pain Drug CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
Figure Global Diabetic Neuropathic Pain Drug Sales Share by Regions (2019-2020)
Table Global Diabetic Neuropathic Pain Drug Sales Revenue (Million USD) by Regions (2015-2020)
Table Global Diabetic Neuropathic Pain Drug CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
Figure Global Diabetic Neuropathic Pain Drug Sales Revenue Share by Regions (2019-2020)
Figure Value Chain Structure of Diabetic Neuropathic Pain Drug
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Diabetic Neuropathic Pain Drug
Figure Cost Structure of Diabetic Neuropathic Pain Drug in 2020
Table Global Diabetic Neuropathic Pain Drug Capacity Share of Manufacturers (2019-2020)
Figure Global Diabetic Neuropathic Pain Drug Capacity Share of Manufacturers (2019-2020)
Table Global Diabetic Neuropathic Pain Drug Sales Market Share of Manufacturers (2019-2020)
Figure Global Diabetic Neuropathic Pain Drug Sales Market Share of Manufacturers (2019-2020)
Table Global Diabetic Neuropathic Pain Drug Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Diabetic Neuropathic Pain Drug Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Diabetic Neuropathic Pain Drug Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
Table ????Astellas Pharma Inc. Profiles
Table ????Astellas Pharma Inc. Diabetic Neuropathic Pain Drug Product Introduction
Table ????Astellas Pharma Inc. Diabetic Neuropathic Pain Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Astellas Pharma Inc. SWOT Analysis
Table ????AstraZeneca Plc Profiles
Table ????AstraZeneca Plc Diabetic Neuropathic Pain Drug Product Introduction
Table ????AstraZeneca Plc Diabetic Neuropathic Pain Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????AstraZeneca Plc SWOT Analysis
Table ????BioDelivery Sciences International, Inc. Profiles
Table ????BioDelivery Sciences International, Inc. Diabetic Neuropathic Pain Drug Product Introduction
Table ????BioDelivery Sciences International, Inc. Diabetic Neuropathic Pain Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????BioDelivery Sciences International, Inc. SWOT Analysis
Table ????Boehringer Ingelheim GmbH Profiles
Table ????Boehringer Ingelheim GmbH Diabetic Neuropathic Pain Drug Product Introduction
Table ????Boehringer Ingelheim GmbH Diabetic Neuropathic Pain Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Boehringer Ingelheim GmbH SWOT Analysis
Table ????Daiichi Sankyo Company, Limited Profiles
Table ????Daiichi Sankyo Company, Limited Diabetic Neuropathic Pain Drug Product Introduction
Table ????Daiichi Sankyo Company, Limited Diabetic Neuropathic Pain Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Daiichi Sankyo Company, Limited SWOT Analysis
Table ????Dong-A Socio Group Profiles
Table ????Dong-A Socio Group Diabetic Neuropathic Pain Drug Product Introduction
Table ????Dong-A Socio Group Diabetic Neuropathic Pain Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Dong-A Socio Group SWOT Analysis
Table ????Eli Lilly and Company Profiles
Table ????Eli Lilly and Company Diabetic Neuropathic Pain Drug Product Introduction
Table ????Eli Lilly and Company Diabetic Neuropathic Pain Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Eli Lilly and Company SWOT Analysis
Table ????Glenmark Pharmaceuticals Ltd. Profiles
Table ????Glenmark Pharmaceuticals Ltd. Diabetic Neuropathic Pain Drug Product Introduction
Table ????Glenmark Pharmaceuticals Ltd. Diabetic Neuropathic Pain Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Glenmark Pharmaceuticals Ltd. SWOT Analysis
Table ????Hydra Biosciences, Inc. Profiles
Table ????Hydra Biosciences, Inc. Diabetic Neuropathic Pain Drug Product Introduction
Table ????Hydra Biosciences, Inc. Diabetic Neuropathic Pain Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Hydra Biosciences, Inc. SWOT Analysis
Table ????Immune Pharmaceuticals Inc. Profiles
Table ????Immune Pharmaceuticals Inc. Diabetic Neuropathic Pain Drug Product Introduction
Table ????Immune Pharmaceuticals Inc. Diabetic Neuropathic Pain Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Immune Pharmaceuticals Inc. SWOT Analysis
Table ????Laboratorios Del Dr. Esteve S.A. Profiles
Table ????Laboratorios Del Dr. Esteve S.A. Diabetic Neuropathic Pain Drug Product Introduction
Table ????Laboratorios Del Dr. Esteve S.A. Diabetic Neuropathic Pain Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Laboratorios Del Dr. Esteve S.A. SWOT Analysis
Table ????Lohocla Research Corporation Profiles
Table ????Lohocla Research Corporation Diabetic Neuropathic Pain Drug Product Introduction
Table ????Lohocla Research Corporation Diabetic Neuropathic Pain Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Lohocla Research Corporation SWOT Analysis
Table ????Mertiva AB Profiles
Table ????Mertiva AB Diabetic Neuropathic Pain Drug Product Introduction
Table ????Mertiva AB Diabetic Neuropathic Pain Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Mertiva AB SWOT Analysis
Table ????Novaremed Profiles
Table ????Novaremed Diabetic Neuropathic Pain Drug Product Introduction
Table ????Novaremed Diabetic Neuropathic Pain Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Novaremed SWOT Analysis
Table ????Pharmaleads Profiles
Table ????Pharmaleads Diabetic Neuropathic Pain Drug Product Introduction
Table ????Pharmaleads Diabetic Neuropathic Pain Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Pharmaleads SWOT Analysis
Table ????RAPID Pharmaceuticals AG Profiles
Table ????RAPID Pharmaceuticals AG Diabetic Neuropathic Pain Drug Product Introduction
Table ????RAPID Pharmaceuticals AG Diabetic Neuropathic Pain Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????RAPID Pharmaceuticals AG SWOT Analysis
Table ????Relmada Therapeutics, Inc. Profiles
Table ????Relmada Therapeutics, Inc. Diabetic Neuropathic Pain Drug Product Introduction
Table ????Relmada Therapeutics, Inc. Diabetic Neuropathic Pain Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Relmada Therapeutics, Inc. SWOT Analysis
Table ????Sphaera Pharma Pvt. Ltd. Profiles
Table ????Sphaera Pharma Pvt. Ltd. Diabetic Neuropathic Pain Drug Product Introduction
Table ????Sphaera Pharma Pvt. Ltd. Diabetic Neuropathic Pain Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Sphaera Pharma Pvt. Ltd. SWOT Analysis
Table ????Theravasc, Inc. Profiles
Table ????Theravasc, Inc. Diabetic Neuropathic Pain Drug Product Introduction
Table ????Theravasc, Inc. Diabetic Neuropathic Pain Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Theravasc, Inc. SWOT Analysis